Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study

The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease

Bartolomé R. Celli, Claudia Côté, José M. Marı́n et al. · New England Journal of Medicine · 2004 · 4K citations · Full text

Health Professions, Physiology, Exercise Testing +16

Global Initiative for Chronic Obstructive Lung Disease (GOLD)

Md Mostafizur Rahman, Md Mahmudur Rahman Siddiqui · Anwer Khan Modern Medical College Journal · 2017 · 3.1K citations · Full text

Medicine, Health Sciences, Pulmonology +8

A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol

James F. Donohue, J.A. van Noord, Eric Bateman et al. · CHEST Journal · 2002 · 469 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium

James F. Donohue, Charles Fogarty, Jan Lötvall et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 356 citations

Pharmacy, Pharmacotherapy, Pulmonary Function Testing +16

Efficacy of a new once-daily long-acting inhaled  2-agonist indacaterol versus twice-daily formoterol in COPD

Ronald Dahl, Kian Fan Chung, Roland Buhl et al. · Thorax · 2010 · 274 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17